The Assured Screening Network offers one of the leading tests for active virus infections via real-time reverse transcription quantitative polymerase chain reaction (RT-qPCR) The test utilises CE-IVD approved test kits allowing use in the UK and Europe.
The laboratory multiplex RT-qPCR kit uses proven primer and probe sequences targeting two different genes from SARS-CoV-2 (assay N1 and assay E) and an internal human control (assay RP). This internal human control ensures that a sufficient quantity of human genetic material has been collected during the sampling process and reduces the risk of false negatives from poorly sampled or unused swabs. The primer and probe sequences have been previously defined by the US Centre for Disease Control (CDC) and the World Health Organisation (WHO) and have been extensively validated for the detection of COVID-19.
- Test Specificity 100%.
- Test Sensitivity >95% at 0.75 copies of viral RNA/µl.
Tests are available for home or business sampling across the UK and Ireland directly through assuredscreening.com or via our network of clinical test partners and resellers.
This is in addition to and complements our antibody testing service.
The Honeyman Group Laboratory uses a myriad of PCR instruments including Qiagen Rotor-gene, Roche LightCycler and the Thermo Piko Real.
The laboratory, with a capacity of up to 20,000 tests per day, is always on stand-by to assist the national testing effort as required.